BIOVIE INC.
BIVIReported to SECin USCIK 0001580149Filings at SEC EDGAR
BIVI is one of 2 listed share classes under this CIK; the filings below cover all of them.
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
Filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Palumbo Joseph MChief Medical Officer | Open-market buy | $10,4614,843 shares | Aug 28, 2026 | Palumbo Joseph MChief Medical Officer | $10,461 | Open-market buy | 4,843 | Aug 28, 2026 |
| Chappell Amy Suzon— | Open-market buy | $1,570727 shares | Aug 28, 2026 | Chappell Amy Suzon | $1,570 | Open-market buy | 727 | Aug 28, 2026 |
| KIM JOANNE WENDYChief Financial Officer | Open-market buy | $5,4502,500 shares | Aug 28, 2026 | KIM JOANNE WENDYChief Financial Officer | $5,450 | Open-market buy | 2,500 | Aug 28, 2026 |
| DO CUONG VPresident & CEO | Open-market buy | $31,63715,210 shares | Aug 28, 2026 | DO CUONG VPresident & CEO | $31,637 | Open-market buy | 15,210 | Aug 28, 2026 |